Pharmaceutical Care for Anticoagulant Therapy in Patients with Heparin Induced Thrombocytopenia Following Orthopedic Surgery
Objective:To explore the process of developing and implementing individualized medication monitoring for patients with heparin induced thrombocytopenia(HIT)and those without HIT following orthopedic surgery.Methods:Clinical pharmacists assess the appropriateness of drug use in patients,consult reference guide,conduct literature search and employ other methods to analyze and discuss relevant factors,thereby assisting doctors in developing and adjusting anticoagulant programs.Results:The patients'platelet counts returned to normal through the development of different platelet monitoring frequencies and individualized medication monitoring.Conclusion:Clinical pharmacists should prioritize monitoring adverse drug reactions and implementing individualized medication monitoring to ensure the safety and effectiveness of drug therapy.
orthopedic surgerylow molecular weight heparinheparin induced thrombocytopeniapharmaceutical careadverse drug reaction